NeuroOne Medical Technologies Corp. (NMTC)
1.62
-0.04
(-2.41%)
USD |
NASDAQ |
Sep 04, 16:00
1.64
+0.02
(+1.23%)
After-Hours: 20:00
NeuroOne Medical Technologies Enterprise Value : 12.23M for Sept. 4, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 12.23M |
| September 03, 2026 | 12.57M |
| September 02, 2026 | 12.66M |
| September 01, 2026 | 12.14M |
| August 31, 2026 | 12.92M |
| August 28, 2026 | 13.53M |
| August 27, 2026 | 15.36M |
| August 26, 2026 | 15.53M |
| August 25, 2026 | 16.93M |
| August 24, 2026 | 16.75M |
| August 21, 2026 | 15.79M |
| August 20, 2026 | 16.84M |
| August 19, 2026 | 17.10M |
| August 18, 2026 | 14.49M |
| August 17, 2026 | 14.49M |
| August 14, 2026 | 15.01M |
| August 13, 2026 | 14.05M |
| August 12, 2026 | 11.36M |
| August 11, 2026 | 12.05M |
| August 10, 2026 | 11.70M |
| August 07, 2026 | 12.31M |
| August 06, 2026 | 11.62M |
| August 05, 2026 | 12.49M |
| August 04, 2026 | 12.84M |
| August 03, 2026 | 12.92M |
| Date | Value |
|---|---|
| July 31, 2026 | 12.84M |
| July 30, 2026 | 12.92M |
| July 29, 2026 | 12.49M |
| July 28, 2026 | 12.66M |
| July 27, 2026 | 13.44M |
| July 24, 2026 | 14.66M |
| July 23, 2026 | 14.23M |
| July 22, 2026 | 14.92M |
| July 21, 2026 | 15.97M |
| July 20, 2026 | 16.93M |
| July 17, 2026 | 18.49M |
| July 16, 2026 | 18.75M |
| July 15, 2026 | 19.97M |
| July 14, 2026 | 19.28M |
| July 13, 2026 | 21.28M |
| July 10, 2026 | 23.19M |
| July 09, 2026 | 22.06M |
| July 08, 2026 | 24.15M |
| July 07, 2026 | 24.41M |
| July 06, 2026 | 25.02M |
| July 02, 2026 | 24.24M |
| July 01, 2026 | 24.24M |
| June 30, 2026 | 24.58M |
| June 29, 2026 | 26.18M |
| June 26, 2026 | 26.18M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 215.11B |
| AngioDynamics, Inc. | 590.94M |
| Alphatec Holdings, Inc. | 1.952B |
| AtriCure, Inc. | 2.527B |
| Baxter International, Inc. | 20.03B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.006M |
| Revenue (Quarterly) | 1.973M |
| Total Expenses (Quarterly) | 3.979M |
| EPS Diluted (Quarterly) | -0.2754 |
| Gross Profit Margin (Quarterly) | 59.94% |
| Profit Margin (Quarterly) | -101.7% |
| Earnings Yield | -56.90% |
| Normalized Earnings Yield | -58.38 |